Chloroprocaine Injection — Competitive Intelligence Brief

Chloroprocaine Injection (Chloroprocaine Injection) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (ester). Area: Anesthesia.

marketed Local anesthetic (ester) Voltage-gated sodium channels Anesthesia Small molecule

Target snapshot

Chloroprocaine Injection (Chloroprocaine Injection) — Nova Scotia Health Authority. Chloroprocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Chloroprocaine Injection TARGET	Chloroprocaine Injection	Nova Scotia Health Authority	marketed	Local anesthetic (ester)	Voltage-gated sodium channels
Triamcinolone acetonide-Ketorolac-Ropivacaine	Triamcinolone acetonide-Ketorolac-Ropivacaine	United Health Services Hospitals, Inc.	marketed	Combination injection (corticosteroid + NSAID + local anesthetic)	Glucocorticoid receptor (triamcinolone); COX-1/COX-2 (ketorolac); voltage-gated sodium channels (ropivacaine)
tetracaine HCl and oxymetazoline HCL	tetracaine HCl and oxymetazoline HCL	Louisiana State University Health Sciences Center in New Orleans	marketed	Local anesthetic with vasoconstrictor combination	Voltage-gated sodium channels (tetracaine); alpha-2 adrenergic receptors (oxymetazoline)
Venlafaxine and Lamotrigine	Venlafaxine and Lamotrigine	University Health Network, Toronto	marketed	SNRI + anticonvulsant combination	Serotonin transporter, norepinephrine transporter, voltage-gated sodium channels, glutamate modulation
Multiple injection local anesthetic	Multiple injection local anesthetic	Hôpital du Valais	marketed	Local anesthetic	Voltage-gated sodium channels
Depofoam bupivacaine	Depofoam bupivacaine	The Cleveland Clinic	marketed	Local anesthetic (liposomal formulation)	Voltage-gated sodium channels
Chloroprocaine 1% Injectable Solution	Chloroprocaine 1% Injectable Solution	Sintetica SA	marketed	Local anesthetic (ester)	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (ester) class)

1. Sintetica SA · 4 drugs in this class
2. Centre Hospitalier Universitaire Saint Pierre · 1 drug in this class
3. Nova Scotia Health Authority · 1 drug in this class
4. American Genomics, LLC · 1 drug in this class
5. University of Miami · 1 drug in this class
6. Wenzhou Medical University · 1 drug in this class
7. Oregon Health and Science University · 1 drug in this class